Back to search
Renal Impairments
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Impairments trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Impairments trials you may qualify forThis is a Phase 1b, multicenter, open-label, PK, and safety study of multiple oral doses of oral decitabine and cedazuridine (formerly known as ASTX727) as a fi…
The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in old…
To Assess the Effect of Severe Hepatic or Renal Impairment on the Pharmacokinetics of Bemnifosbuvir/Ruzasvir After a Single Dose
The objective of this study is to investigate the PK, PD, safety, and tolerability of ivosidenib in adult participants with IDH1-mutated malignancies and hepati…
The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to lea…
Patients with renal insufficiency who undergo cardiac surgery with cardiopulmonary bypass (CPB) are at significant risk for exacerbation of renal dysfunction po…
Patients with chronic kidney disease receiving hemodialysis (HD) suffer from higher rates of brain vascular disease and decreased cognition than the general pop…
The purpose of this study is to assess the effect of renal impairment on the pharmacokinetics of enpatoran.
To evaluate the pharmacokinetic characteristics of pyroglutamate rongliflozin capsules in type 2 diabetic subjects with normal renal function and mild to modera…